The change in EpCAM expression between Trp53 KO iKrasG12D primary and reactivated tumors, suggested a switch in tumor type since EpCAM is an epithelial cell marker usually absent in mesenchymal tumors. This evidence concerns the gene EPCAM and neoplasm.